Side effects of taking Sotorasib for lung cancer

Sotorasib (Sotorasib) is a targeted therapy for KRAS G12C mutated non-small cell lung cancer (NSCLC). Although it can provide hope, it may also be accompanied by some side effects during use. The degree and manifestation of side effects vary from person to person. The following are some possible side effects that require the attention of patients and doctors during treatment:

Common side effects:

1.Respiratory problems: Some patients may experience respiratory problems, including coughing, shortness of breath, and shortness of breath. This may be related to lung inflammation or other respiratory-related reactions.

2.Skin Reactions: Sotoraxib may cause skin problems, such as rash, itching, dryness, etc. Some patients may experience more significant skin reactions that require close attention and reporting to their doctor.

3.Nausea and Loss of Appetite: Some patients may experience digestive problems such as nausea, vomiting, or loss of appetite while taking sotoraxib. This may affect the patient's nutritional status and quality of life.

4.Abnormal liver function: Some patients may experience abnormal liver function when taking sotoraxib, manifesting as jaundice, fatigue, upper abdominal discomfort and other symptoms. This requires prompt monitoring and management to avoid further liver damage.

Rare but serious side effects:

1.Pulmonary inflammation: There are reports that pulmonary inflammation, including interstitial lung disease, may occur during the use of sotorasibu. Patients should undergo periodic lung imaging during use to detect potential lung problems.

2.Eye problems: Some patients may experience eye problems, including dry eyes, eye pain, blurred vision, etc. These problems may require further evaluation and management by an ophthalmologist.

3.Cardiovascular problems: Although rare, some patients may develop cardiovascular problems, such as high blood pressure, heart palpitations, etc. when using sotoracib. Patients should closely monitor their blood pressure and heart condition while taking this medication.

Notes and suggestions:

1.Regular monitoring: During the period of using sotoracib, doctors will recommend that patients undergo regular physiological and imaging monitoring, as well as laboratory tests when necessary, to evaluate the efficacy and side effects of treatment.

2.Prompt reporting: Patients should promptly report any new symptoms or discomfort to their doctor while using sotoracib. This helps doctors adjust treatment plans in a timely manner to ensure patient safety and efficacy.

3.Individualized treatment: Since each patient’s physical condition and illness are different, the treatment plan needs to be individualized. Doctors will adjust the medication plan according to the patient's specific situation to balance efficacy and side effects.

4.Comprehensive evaluation: Before using sotorasiib, doctors usually conduct a comprehensive patient evaluation, including physical examination, physiological indicators and the patient's medical history. This can help determine if there are potential contraindications or special considerations.

Although sotorasiib provides a new treatment option for someNSCLC patients, patients still need to closely follow their doctor's recommendations when using the drug and have regular follow-up visits to ensure optimal treatment effects and minimize possible side effects. During the treatment process, timely communication and cooperation are the keys to ensuring patient health.

The original drug of sotorasibu has not yet been launched in China, so patients cannot purchase it domestically and need to purchase sotorasibu through overseas channels. The price of the original version of sotorasibu in Hong Kong, China, with the specifications of 120mg*240 tablets, is around 8 million, and the price of the European version of the original drug with the same specifications is around 4 million, which is relatively expensive. The cheaper ones are the generic drugs marketed abroad. For example, the price of generic drugs in Laos and Bangladesh is around two to three thousand yuan. The price is relatively cheap, and the ingredients of foreign generic drugs are basically the same as the original drugs.